P11.17 Splicing dysregulation drives glioblastoma malignancy: SRSF3 as a potential therapeutic target to impair glioblastoma progression

Glioblastomas (GBMs) remain the deadliest human brain tumors, with poor prognosis despite years of research. Currently, standard therapeutic strategies to treat GBM are not efficient and common survival from diagnosis is ~12–16 months. Thus, identification of new diagnostic/prognostic/therapeutic to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Fuentes-Fayos, A C, Vázquez-Borrego, M C, Jiménez-Vacas, J M, Bejarano, L, Blanco-Acevedo, C, Sánchez-Sánchez, R, Solivera, J, Blasco, M A, Castaño, J P, Luque, R M
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Poster Presentations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796159/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.163
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker